We are live on ! Find out more
ZURA icon

Zura Bio

25 hedge funds and large institutions have $48.5M invested in Zura Bio in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

884% more capital inflows, than outflows

Capital inflows: $18.7M | Capital outflows: $1.9M

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

47% more funds holding

Funds holding: 17 → 25 (+8)

12.34% more ownership

Funds ownership: 23.27% → 35.61% (+12%)

Holders
25
Holders Change
+8
Holders Change %
+47.06%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
1
Closed
3
Calls
$214​K
Puts
–
Net Calls
+$214​K
Net Calls Change
+$214​K

ZURA Hedge Fund Activity: Q4 2021 in Review

25 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2021, worth a combined $48.5M — up 54% from $31.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ZURA positions and 3 closed out — a net gain of 8 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $4.44M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $1.47M sold.

  • 25 institutional investors held Zura Bio (ZURA) as of Q4 2021, up from 17 in Q3 2021.
  • Funds reported $48.5M of Zura Bio stock for Q4 2021, up 54% quarter-over-quarter.
  • 11 funds opened new Zura Bio positions in Q4 2021 and 3 closed out, a net change of +8 holders.
  • The largest Zura Bio buyer in Q4 2021 was Owl Creek Asset Management, an estimated $4.44M added.
  • The largest Zura Bio seller in Q4 2021 was Oaktree Capital Management, an estimated $1.47M sold.

Based on aggregated 13F filings for Q4 2021.